On the basis of the established role of IL-1β in SJIA pathogenesis [10], and the diagnostic hypothesis that the increased platelet number and the pericardial effusion were signs of systemic involvement, we started a treatment with Anakinra that brought about a dramatic improvement in the patient’s overall clinical conditions. This evidence concerns the gene IL1B and pericardial effusion.